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BRIEF COMMUNICATION
Early gastric cancer (EGC) was defined in 1962 by
the Japanese Research Society as gastric cancers
that are limited to the mucosa or submucosa re-
gardless of the presence of lymph node metasta-
sis.1 In Japan, the 5-year survival rate of patients
with EGC is more than 90% after gastrectomy
with complete removal of the primary and sec-
ondary lymph nodes.2,3 The incidence of nodal
metastasis of intramucosal and submucosal EGCs
has been reported to be 3% and 20%, respec-
tively.4 Endoscopic mucosal resection (EMR) for
EGC was first performed in Japan in 1983. The
original strip biopsy technique was advocated by
Tada et al.5 Modifications in EMR by using a
transparent cap (EMR-C) were developed by Inoue
et al6 and were commonly used for treatment of
early gastroesophageal tumors. However, it is dif-
ficult to remove gastroesophageal cancers larger
than 2 cm and those with ulceration or submu-
cosal fibrosis using the strip biopsy method and
EMR-C. In Taiwan, EMR for EGCs is not fre-
quently used because most gastric cancers are di-
agnosed in an advanced stage. We previously
reported EMR-C for an EGC with focal submu-
cosal invasion in a patient with decompensated
liver cirrhosis.7 Hosokawa developed a new endo-
scopic knife, an insulation-tipped diathermic
knife (IT-knife), which has a ceramic ball at the
top of the incising needle to prevent leakage of
electricity toward the deeper layer of the stom-
ach.8 The device was introduced into clinics in
1994.8 Hosokawa and Yoshida provided a better
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It is difficult to remove a large early gastric cancer (≥ 3 cm) in one-piece resection using conventional 
endoscopic mucosal resection. We tried to use an insulation-tipped (IT) diathermic knife to dissect these
lesions. IT-endoscopic submucosal dissection (ESD) was performed in four aging patients with gastric 
malignancy. All lesions could be removed in one-piece resection by IT-ESD, although three of them exhibited
remarkable fibrosis and ulceration. Three cases experienced curative treatment with IT-ESD after the
pathologic evaluation, but it was not curative in one case because the pathology showed angiolymphatic
invasion. This patient refused additional surgery in consideration of existing major systemic diseases. At 3
months to 1 year of follow-up, endoscopy showed no evidence of residual cancer. IT-ESD is effective in the
treatment of large early gastric cancer and is an alternative treatment for early gastric cancer patients who are
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method for en bloc resection of gastric neoplasms
larger than 30 mm in size.9,10 The indication for
endoscopic submucosal dissection (ESD) of EGCs
has been expanded in the National Cancer Center
Hospital in Japan according to Gotoda et al’s 
report.11 ESD with an IT-knife has rarely been 
reported in Taiwan. Here, we report four patients
with large (≥ 3 cm) EGCs or high-grade dysplasia
who were successfully treated by IT-ESD.
Patients and Methods
Case 1
A 67-year-old man with parkinsonism for 13
years under medical control complained of epigas-
tric pain for 5 months. Upper gastrointestinal
(UGI) endoscopy was performed and revealed a
gastric ulcer at the lesser curvature of the gastric
antrum. After 2 months of proton pump inhibitor
(PPI) therapy, the ulcer healed. However, an ery-
thematous depressed area with central scarring
and irregular margin at the previous location of
the ulcer was found (Figure A). Chromoendoscopy
demonstrated the lesion more prominently after
using 0.2% indigo carmine (Figure B). Biopsies
showed severe dysplasia. In addition, endoscopic
ultrasound (EUS) (UM-2R; Olympus Optical Co.
Ltd., Tokyo, Japan) showed only thickening of the
first and second layer of the gastric wall and no
evidence of perigastric lymph nodes. Because the
lesion was larger than 3 cm and had central scar-
ring, it would have been difficult to resect it in one
piece using conventional EMR. Under general
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Figure. (A) An erythematous depressed area with central scarring and irregular margin at the lesser curvature of the gas-
tric antrum. (B) Chromoendoscopy shows the lesion more prominently after using 0.2% indigo carmine. (C) A large 
active ulcer is found after IT-ESD in case 1. (D) Microscopically, the greatest extent of the mucosal depressed area shows
a picture of an intramucosal adenocarcinoma. Remarkable fibrosis in the submucosa can be seen (hematoxylin & 
eosin, 40×).
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anesthesia, we first marked the margin of the
tumor with a needle knife (KD-1L; Olympus
Optical Co. Ltd.) to ensure a cancer-free margin
and complete resection. Then we injected 1–4 mL
of normal saline plus indigo carmine into the sub-
mucosa to lift the lesion. Circumferential incision
was done initially, then ESD was smoothly per-
formed with the IT-knife (KD-610L; Olympus
Optical Co. Ltd.). The electrosurgical unit (PSD-
60; Olympus Optical Co. Ltd.) was used and the
Endocut mode (80W, Effect 3) was set. A large
active ulcer was found after IT-ESD (Figure C).
The characteristics of the tumor are shown in the
Table. All surgical margins were free of the carci-
noma. Remarkable fibrosis in the submucosa
was also seen (Figure D). At the 3-, 6-, 9-, and 14-
month follow-ups, endoscopy showed no evi-
dence of residual cancer or local recurrence after
the biopsies were displayed.
Case 2
A 77-year-old man with diabetes mellitus, chronic
renal insufficiency, and ischemic heart disease
for years under medical control complained of
epigastric pain for 2 months, which could some-
times be relieved with antacids. UGI endoscopy
was performed and revealed an ulceration with ir-
regular nodular margin at the posterior wall of the
gastric antrum. Endoscopic biopsies showed severe
dysplasia. Repeat UGI endoscopy and biopsy
proved a moderately differentiated adenocarci-
noma. Abdominal CT scan and EUS showed no
evidence of distant metastasis and no enlarged
lymph nodes. This patient refused subtotal gastrec-
tomy because of major systemic diseases. IT-ESD
was performed smoothly. The characteristics of the
tumor are shown in the Table. The tumor ex-
tended into the submucosa and was very close to
the deep surgical margin. In addition, lymphatic-
capillary permeation was frequently seen. Obvi-
ously, this procedure was not curative for him. We
suggested additional surgery but he and his fam-
ily refused again due to chronic renal insufficiency
and ischemic heart disease. At the 3-month fol-
low-up, endoscopic biopsy showed no evidence
of residual cancer or local recurrence. Unfortu-
nately, he died of acute myocardial infarction
and congestive heart failure 6 months after ESD.
Table. Characteristics of patients who underwent endoscopic submucosal dissection for early gastric cancer or 
high-grade dysplasia
Patient
Age (yr)/
Macroscopic Tumor size (cm)/
Pathologic
Time needed 
Curative
Cancer-
gender
type/tumor resected specimen
diagnosis
for operation
treatment
free 
location size (cm)
(hr)/blood interval
loss (mL) (mo)
1 67/male IIc/gastric 2.6 × 2.2/4 × 3.3 Well-differentiated 3/50 Yes 18
antrum adenocarcinoma,
intramucosa
2 77/male Iia + IIc/gastric 3 × 1.8/5.2 × 4.9 Moderately 2.5/50 No (cut margin 3 
antrum differentiated free of cancer but
adenocarcinoma, with lymphatic-
submucosa vascular invasion)
3 72/male IIc/gastric 2.5 × 1.5/4 × 3.5 Moderately 2.5/30 Yes 6
angle differentiated
adenocarcinoma,
intramucosa
4 60/male IIa/gastric 3.5 × 2.8/4.8 × 3.8 High-grade 3.5/150 Yes 3
antrum dysplasia, 
intramucosa
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Cases 3 and 4
IT-ESD was performed smoothly for these two
patients. The basic data of the patients and the
characteristics of the tumors are shown in the
Table. There was no evidence of residual cancer
and local recurrence on follow-up endoscopy.
Discussion
Surgery has been considered the gold standard
treatment for EGC. However, the surgical treatment
of EGC is associated with substantial costs as well
as risks. Gastrectomy has an operative mortality
rate of between 1% and 6.5%.12,13 A Dutch study
reported a 10% mortality rate and a 43% compli-
cation rate.14 Even after curative surgery, the qual-
ity of life may be reduced because of early fullness
during eating, dysphagia, reflux symptoms, abdo-
minal discomfort, diarrhea, vomiting, postprandial
sweating, and fatigue.15–17 For the past 20 years,
EMR for EGC has been widely performed as a stan-
dard method in Japan. The empirical indication
for EMR is intestinal-type mucosal cancers with-
out ulcerative findings, ≤ 2 cm in size if elevated
or ≤ 1 cm in size if depressed or flat. The Japanese
Gastric Cancer Association issued the first version
of their gastric cancer treatment guidelines in 2001,
which stated that endoscopic resection was indi-
cated for intestinal-type mucosal cancers without
ulcerative findings, ≤ 2 cm in size, regardless of
tumor morphology.18 These criteria were deter-
mined by considering two aspects: being free of
lymph node metastasis and probability of success-
ful en bloc resection. The technique of EMR has
improved and ESD can dissect a larger lesion.
Therefore, the indication for EMR for EGC could
be expanded to all those tumors that have been
described as node-negative tumors including 
superficial submucosal invasion.11,19
In our cases, endoscopic biopsies from an ulcer-
ative tumor provided a limited pathologic finding
such as severe dysplasia. It is better to treat these
lesions with PPI for 1–2 months. After the ulcer
has healed, it is easier to obtain an accurate
pathology from endoscopic biopsies. Moreover,
invasive cancer can be understaged as severe dys-
plasia without complete resection of the tumor.
Therefore, we consider that EMR is indicated for
those with a pathology disclosing severe dysplasia.
With conventional EMR methods including
the strip biopsy method and EMR-C, it is difficult
to remove gastroesophageal cancers larger than
2 cm and those with ulceration or submucosal 
fibrosis. When performing EMR, en bloc resection
is the optimal method, because it is often diffi-
cult to reconstruct an entire lesion from multiple
specimen fragments; multiple specimen fragments
do not contribute to accurate histopathologic eval-
uation of resected margin and angiolymphatic
invasion.10 Therefore, we treated these four patients
suffering from large early gastric tumors (≥3 cm)
with or without central ulceration and fibrosis
by IT-ESD rather than by conventional EMR. We
also carried out one-piece resection in these four
patients. In Ohkuwa et al’s8 study, the one-piece
(en bloc) resection rate for tumors between 11 mm
and 20 mm in size was lower at 29% (5/17), com-
pared with a rate of 75% (12/16) for similarly
sized lesions treated with IT-ESD. One-piece resec-
tion can reduce the local recurrence rate of gastric
cancer after EMR.9,10
IT-ESD is one kind of advanced EMR with a
relatively high risk of bleeding and perforation.
In addition, IT-ESD is more time-consuming than
conventional EMR. From Hamanaka et al’s report,
it took more than 2 hours to dissect the EGC with
IT-ESD in 14% of the patients they treated.
Furthermore, major complications such as perfo-
ration and bleeding occurred in 4% and 2%, re-
spectively.20 In our studies, the operation time
was around 2–3 hours. Meanwhile, neither major
bleeding nor perforation was encountered in
these four patients. Although these four patients
had large early gastric tumors and three of them
had central ulcer and fibrosis, we were able to dis-
sect and exfoliate the ulcerative and fibrotic part
with the IT-knife without difficulty.
In conclusion, our preliminary experience re-
vealed IT-ESD to be effective for large EGC with
central fibrosis and ulceration and for those who
are at high risk for major operation or those who
C.C. Chang, et al
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refuse surgery. But it is not recommended for in-
experienced endoscopists considering the high
level of skill needed and a relatively higher risk
of complications.
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